Zotum 500mg Tablet contains Cefuroxime, a second-generation cephalosporin antibiotic effective against a broad spectrum of bacterial infections. It acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. Indicated for the treatment of respiratory tract infections, urinary tract infections, skin and soft tissue infections, and Lyme disease, Zotum is suitable for both adult and pediatric patients. The 500mg dosage provides an optimal balance between efficacy and safety, ensuring adequate plasma concentrations to combat susceptible pathogens. Cefuroxime exhibits activity against Gram-positive and Gram-negative bacteria, including Streptococcus pneumoniae, Haemophilus influenzae, and Escherichia coli. It is administered orally, with good bioavailability and tissue penetration. Common adverse effects may include gastrointestinal disturbances such as diarrhea, nausea, and abdominal pain, while hypersensitivity reactions, though rare, require immediate medical attention. Caution is advised in patients with a history of penicillin or cephalosporin allergy. Dose adjustment may be necessary in renal impairment. Zotum 500mg Tablet should be used under medical supervision, adhering to prescribed dosage and duration to prevent resistance development. It is contraindicated in patients with known hypersensitivity to cefuroxime or other cephalosporins.